(Q43724123)

26 November 2017

title

EBV replicon vector system enhances transgene expression in vivo: applications to cancer gene therapy (English)

1 reference

26 November 2017

0 references

1 reference

Otomo T

1

1 reference

26 November 2017

Yamamoto S

series ordinal

2

1 reference

26 November 2017

Morishita R

series ordinal

3

1 reference

26 November 2017

Kaneda Y

series ordinal

4

1 reference

26 November 2017

publication date

1 July 2001

1 reference

26 November 2017

published in

Journal of Gene Medicine

1 reference

26 November 2017

volume

3

1 reference

26 November 2017

issue

4

1 reference

26 November 2017

page(s)

345-352

1 reference

Paracrine cytokine adjuvants in cancer immunotherapy

26 November 2017

cites work

1 reference

Induction of antigen-specific T cell anergy: An early event in the course of tumor progression

21 January 2018

1 reference

Self antigens expressed by solid tumors Do not efficiently stimulate naive or activated T cells: implications for immunotherapy

21 January 2018

1 reference

Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir

21 January 2018

1 reference

Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells

21 January 2018

1 reference

Nonviral gene therapy: the promise of genes as pharmaceutical products

21 January 2018

1 reference

In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector

21 January 2018

1 reference

Gene delivery: a single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus

21 January 2018

1 reference

The potential of extrachromosomal replicating vectors for gene therapy

21 January 2018

1 reference

Sustained transgene expression in vitro and in vivo using an Epstein-Barr virus replicon vector system combined with HVJ liposomes

21 January 2018

1 reference

An enhanced EBNA1 variant with reduced IR3 domain for long-term episomal maintenance and transgene expression of oriP-based plasmids in human cells

21 January 2018

1 reference

Highly efficient suicide gene expression in hepatocellular carcinoma cells by epstein-barr virus-based plasmid vectors combined with polyamidoamine dendrimer

21 January 2018

1 reference

Covalently closed circular duplex DNA of Epstein-Barr virus in a human lymphoid cell line

21 January 2018

1 reference

Mapping genetic elements of Epstein-Barr virus that facilitate extrachromosomal persistence of Epstein-Barr virus-derived plasmids in human cells

21 January 2018

1 reference

Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region

21 January 2018

1 reference

A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components

21 January 2018

1 reference

trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1.

21 January 2018

1 reference

Gene therapy using HVJ-liposomes: the best of both worlds?

21 January 2018

1 reference

Prolonged transgene expression in glomeruli using an EBV replicon vector system combined with HVJ liposomes

21 January 2018

1 reference

Enhancement of transgene expression by cotransfection of oriP plasmid with EBNA-1 expression vector

21 January 2018

1 reference

Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells

21 January 2018

1 reference

Development and characterization of cationic liposomes conjugated with HVJ (Sendai virus): reciprocal effect of cationic lipid for in vitro and in vivo gene transfer

21 January 2018

1 reference

Reactivation of silenced, virally transduced genes by inhibitors of histone deacetylase

21 January 2018

1 reference

Amplification of recombinant adenoviral transgene products occurs by inhibition of histone deacetylase

21 January 2018

1 reference

Amplification of transgene expression in vitro and in vivo using a novel inhibitor of histone deacetylase.

21 January 2018

1 reference

Persistent gene expression in rat liver in vivo by repetitive transfections using HVJ-liposome

21 January 2018

1 reference

Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation

21 January 2018

1 reference

Epstein-Barr virus (EBV)-encoded membrane protein LMP1 from a nasopharyngeal carcinoma is non-immunogenic in a murine model system, in contrast to a B cell-derived homologue.

21 January 2018

1 reference

Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation

21 January 2018

1 reference

Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes

21 January 2018

1 reference

21 January 2018

1 reference

Human gene marker/therapy clinical protocols (complete updated listings)

21 January 2018

1 reference

The oncogenic potential of Epstein-Barr virus nuclear antigen 1 in transgenic mice

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JGM.199

1 reference

26 November 2017

1 reference